Wataru Endo, Liverpool’s determined midfielder, has clocked just 85 minutes on the pitch this season. Despite this limited game time, the 31-year-old Japanese international remains committed to ...

A 22-year-old blind Appaloosa horse named Endo has set three Guinness World Records. Endo, also known as "Endo the Blind," set records for the highest free jump by a blind horse at 3 feet and 5.73 ...

Endo is a diversified pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these essential medicines.

NEW YORK (Reuters) - Bankrupt drugmaker Endo International said on Wednesday the federal government's opposition to its bankruptcy sale threatened to undo nearly $600 million in settlements reached ...

Endo has brought all hands on deck for its newest campaign to raise awareness about Dupuytren’s contracture and its available treatments. Dupuytren’s is a progressive condition in which the tissue ...

Endo International, a pharmaceutical company whose U.S. headquarters is in Malvern, Pennsylvania, has agreed to pay the government up to $465 million to settle civil and criminal investigations into ...

US healthcare company Endo Health Solutions has acquired Canada-based specialty pharma company Paladin Labs in a deal worth up to US $1.6 billion. Paladin Labs focuses on acquiring or in-licensing ...

Having spent the better part of the decade grappling with bankruptcy bids and opioid settlements, troubled drugmakers Mallinckrodt and Endo have decided to join forces to create a more flexible ...

NEW YORK (Reuters) -Bankrupt drugmaker Endo International will pay up to $465 million to settle the federal government's law enforcement, tax, and healthcare cost claims, the U.S. Department of ...

With every crunching tackle, vital interception and kick to his face, Wataru Endo is steadily becoming something of a cult hero at Liverpool. Ask the club’s supporters who they most like watching and ...

MALVERN, Pa., March 11, 2025 /CNW/ -- Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI) today announced it has entered into a definitive agreement to divest its International Pharmaceuticals business ...